Node negative breast cancerCOOMBES, R. C.Pathologie et biologie. 1994, Vol 42, Num 10, issn 0369-8114, p. 958Conference Paper

Second generation aromatase inhibitor : 4-hydroxyandrostenedioneDOWSETT, M; COOMBES, R. C.Breast cancer research and treatment. 1994, Vol 30, Num 1, pp 81-87, issn 0167-6806Article

Multiple forms of TGF-β₁ in breast tissues : a biologically active form of the small latent complex of TGF-β₁BAILLIE, R; COOMBES, R. C; SMITH, J et al.European journal of cancer (1990). 1996, Vol 32, Num 9, pp 1566-1573, issn 0959-8049Article

1,25-dihydroxyvitamin D₃ binding in estrogen-responsive rat breast tumorCOLSTON, K; WILKINSON, J. R; COOMBES, R. C et al.Endocrinology (Philadelphia). 1986, Vol 119, Num 1, pp 397-403, issn 0013-7227Article

Possible role for vitamin D in controlling breast cancer cell proliferationCOLSTON, K. W; BERGER, U; COOMBES, R. C et al.Lancet (British edition). 1989, Num 8631, pp 188-191, issn 0140-6736, 4 p.Article

Expression of basic fibroblast growth factor, FGFR1 and FRFR2 in normal and malignant human breast, and comparison with other normal tissuesLUQMANI, Y. A; GRAHAM, M; COOMBES, R. C et al.British journal of cancer. 1992, Vol 66, Num 2, pp 273-280, issn 0007-0920Article

Polymerase chain reaction-aided analysis of gene expression in frozen tissue sectionsLUQMANI, Y. A; SMITH, J; COOMBES, R. C et al.Analytical biochemistry. 1992, Vol 200, Num 2, pp 291-295, issn 0003-2697Article

Growth factor expression in breast tissueCOOMBES, R. C; BARRETT-LEE, P; LUQMANI, Y et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 833-836, issn 0960-0760, 4 p.Conference Paper

Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapyHARPER-WYNNE, C; COOMBES, R. C.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 744-746, issn 0959-8049Article

Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patientsDOWSETT, M; STEIN, R. C; MEHTA, A et al.Clinical endocrinology (Oxford. Print). 1990, Vol 32, Num 5, pp 623-634, issn 0300-0664, 12 p.Article

The effect of endocrine therapy on fibroblast growth factor-like activity in nitrosomethylurea-induced rat mammary tumoursSMITH, J; CHANDER, S. K; BAILLIE, R et al.European journal of cancer. Part A. 1993, Vol 29, Num 15, pp 2125-2131Article

Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)GAZET, J.-C; FORD, H. T; COOMBES, R. C et al.British journal of cancer. 1991, Vol 63, Num 2, pp 279-282, issn 0007-0920Article

Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies = Cytotoxicité cellulaire anticorps dépendante contre les cellules cancéreuses de sein humain en culture par les cellules effectrices humaines à l'aide d'anticorps monoclonaux et polyclonauxGORE, M. E; SKILTON, R. A; COOMBES, R. C et al.British journal of cancer. 1983, Vol 48, Num 6, pp 877-879, issn 0007-0920Article

4-hydroxyandrostenedione : a new treatment for postmenopausal patients with breast cancerCOOMBES, R. C; HUGHES, S. W. M; DOWSETT, M et al.European journal of cancer. Part A. 1992, Vol 28, Num 12, pp 1941-1945Article

CA-125 is not a useful marker in metastatic breast cancerSECKL, M. J; RUSTIN, G. J. S; COOMBES, R. C et al.British journal of cancer. 1992, Vol 66, Num 5, pp 875-876, issn 0007-0920Article

An immunohistochemical survey of pS2 expression in human epithalial cancersLUQMANI, Y. A; RYALL, G; SHOUSHA, S et al.International journal of cancer. 1992, Vol 50, Num 2, pp 302-304, issn 0020-7136Article

Metal complexes of symmetric and non-symmetric tetradentate Schiff bases derived from 1-(2-mercaptophenyl)-ethanoneCOOMBES, R. C; COSTES, J. P; FENTON, D. E et al.Inorganica chimica acta. 1983, Vol 17, Num 5, pp L173-L174, issn 0020-1693Article

Transcripts for transforming growth factors in human breast cancer: clinical correlatesBARRETT-LEE, P; TRAVERS, M; LUQMANI, Y et al.British journal of cancer. 1990, Vol 61, Num 4, pp 612-617, issn 0007-0920Article

Experience with intermediate-dose (110-120 mg/m²) epirubicinHICKISH, T; CUNNINGHAM, D; HAYDOCK, A et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 1, pp 61-64, issn 0344-5704Article

Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZFBULUWELA, L; PIKE, J; SCHWICKERATH, O et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 5, pp 452-460, issn 0969-7128, 9 p.Article

An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancersTAYLOR, J; LYMBOURA, M; PACE, P. E et al.International journal of cancer. 1998, Vol 79, Num 4, pp 334-342, issn 0020-7136Article

Fibroblast growth factor 2 in breast cancer : occurrence and prognostic significanceYIANGOU, C; GOMM, J. J; COOPE, R. C et al.British journal of cancer. 1997, Vol 75, Num 1, pp 28-33, issn 0007-0920Article

The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissueCOOPE, R. C; BROWNE, P. J; YIANGOU, C et al.British journal of cancer. 1997, Vol 75, Num 11, pp 1621-1630, issn 0007-0920Article

Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer : results of a randomized trialCOOMBES, R. C; BLISS, J. M; PEREZ-LOPEZ, C. M et al.Journal of clinical oncology. 1996, Vol 14, Num 1, pp 35-45, issn 0732-183XArticle

Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometryPOON, G. K; VIGUSHIN, D; GRIGGS, L.J et al.Drug metabolism and disposition. 1996, Vol 24, Num 5, pp 565-571, issn 0090-9556Article